Growth dynamics of incidental meningiomas: A prospective long-term follow-up study.
Torbjørn Austveg StrømsnesMorten Lund-JohansenGeir Olve SkeieGeir Egil EideMaziar BehbahaniBente Sandvei SkeiePublished in: Neuro-oncology practice (2022)
Active monitoring seems a safe and appropriate first-line management of incidental meningiomas. Intervention was avoided in > 40% with indolent tumors in this cohort. Treatment was not compromised by tumor growth. Clinical follow-up seems sufficient beyond 5 years if self-limiting growth is established. Steady or accelerating growth warrant monitoring until they reach a stable state or intervention is initiated.
Keyphrases